Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

3.50
Delayed Data
As of 3:59pm ET
 -0.25 / -6.67%
Today’s Change
2.60
Today|||52-Week Range
6.80
-31.37%
Year-to-Date
Company News For Oct 10, 2017
Oct 10 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.75
Today’s open3.70
Day’s range3.45 - 3.73
Volume105,576
Average volume (3 months)116,119
Market cap$191.7M
Dividend yield--
Data as of 3:59pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)-55.00%
Earnings growth (this year)-17.74%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.33%
P/E ratioNM
Price/Sales364.28
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.03+0.72%
VSTMVerastem Inc-0.07-1.77%
VBIVVBI Vaccines Inc-0.15-4.25%
VBLTVascular Biogenics L...+0.20+3.33%
Data as of 4:00pm ET, 10/23/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$712.0K
Annual profit (last year)-$31.5M
Net profit margin-4,425.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-
Chief Executive Officer
Martin S. Gerstel
President &
Co-Chief Executive Officer
Anat Cohen-Dayag
Corporate headquarters
Holon, Tel Aviv

Forecasts